US 7763586
Melanoma antigens and their use in diagnostic and therapeutic methods
granted A61KA61K2039/5256A61K2039/53
Quick answer
US patent 7763586 (Melanoma antigens and their use in diagnostic and therapeutic methods) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/5256, A61K2039/53, A61K2239/31, A61K2239/38